Doris Rau
26Patents
7h-index
42Co-inventors
65Inventor score
Filing activity: Oct 10, 2006 → Sep 20, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8236308B2 | Composition comprising cross-species-specific antibodies and uses thereof | Chemistry; Metallurgy | 175 | Active |
| US9150664B2 | Binding molecules for BCMA and CD3 | Chemistry; Metallurgy | 54 | Active |
| US9340621B2 | Binding molecules for BCMA and CD3 | Chemistry; Metallurgy | 51 | Active |
| US9587036B2 | Cross-species-specific PSMAxCD3 bispecific single chain antibody | Chemistry; Metallurgy | 23 | Active |
| US8394926B2 | Pharmaceutical compositions with resistance to soluble CEA | Chemistry; Metallurgy | 18 | Active |
| US9598500B2 | Binding molecules for BCMA and CD3 | Chemistry; Metallurgy | 17 | Active |
| US10519241B2 | Antibody constructs for EGFRVIII and CD3 | Chemistry; Metallurgy | 14 | Active |
| US10059766B2 | Antibody constructs for CDH19 and CD3 | Chemistry; Metallurgy | 7 | Active |
| US10752694B2 | Binding molecules for BCMA and CD3 | Chemistry; Metallurgy | 5 | Active |
| US10766969B2 | Binding molecules for BCMA and CD3 | Chemistry; Metallurgy | 4 | Active |
| US8901278B2 | Pharmaceutical antibody compositions with resistance to soluble CEA | Chemistry; Metallurgy | 3 | Active |
| US10981998B2 | Cross-species-specific single domain bispecific single chain antibody | Chemistry; Metallurgy | 3 | Active |
| US11472886B2 | Cross-species-specific PSMAxCD3 bispecific single chain antibody | Chemistry; Metallurgy | 2 | Active |
| US9695250B2 | Pharmaceutical compositions with resistance to soluble CEA | Chemistry; Metallurgy | 2 | Active |
| US9982063B2 | Pharmaceutical compositions with resistance to soluble CEA | Chemistry; Metallurgy | 2 | Active |
| US11155629B2 | Method for treating glioblastoma or glioma with antibody constructs for EGFRVIII and CD3 | Chemistry; Metallurgy | 1 | Active |
| US12152078B2 | Nucleic acids encoding anitbody constructs binding EGFR VIII and CD3 | Chemistry; Metallurgy | 0 | Active |
| US11884720B2 | Antibody constructs for MSLN and CD3 | Chemistry; Metallurgy | 0 | Active |
| US11498964B2 | Antibody constructs for CDH19 and CD3 | Chemistry; Metallurgy | 0 | Active |
| US12281175B2 | Binding molecules for BCMA and CD3 | Chemistry; Metallurgy | 0 | Active |
| US11987633B2 | Cross-species-specific single domain bispecific single chain antibody | Chemistry; Metallurgy | 0 | Active |
| US11925684B2 | Compositions comprising cross-species-specific antibodies and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US12281176B2 | Binding molecules for BCMA and CD3 | Chemistry; Metallurgy | 0 | Active |
| US12281172B2 | Cross-species-specific PSMAxCD3 bispecific single chain antibody | Chemistry; Metallurgy | 0 | Active |
| US11926666B2 | Bispecific antibody constructs for CDH3 and CD3 | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.